Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease

NCT04255875 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Sickle Cell Anemia

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: PF-07209326
BIOLOGICAL: PF-07209326

Sponsor

Pfizer